GDF15 and prostate carcinoma: In the same model of mouse prostate cancer overexpressing GDF15 in myeloid cells (Gdf15Csf1R mice described above) that exhibit a reported elevation of circulating GDF15 between 10 and 90-fold, reduced local tumor burden as expected, although the rate of metastasis was unexpectedly increased (195).